ArticleOdontology2026
Uncovering the hidden costs of Molar Incisor Hypomineralization (MIH): the impact of later diagnosis on clinical outcomes and financial cost.
Article in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Molar Incisor Hypomineralization (MIH) is a dynamic condition in which demarcated opacities can progress to post-eruptive enamel breakdown, increasing the risk of dental caries. This study aimed to evaluate the clinical and economic impact of late diagnosis of MIH. A total of 803 children aged 6-11 years were examined, of whom 172 were diagnosed with MIH and classified into 2 groups based on age at diagnosis: early diagnosis (under 8 years) and late diagnosis (8 years or older). A treatment plan was developed according to the severity and clinical presentation of MIH in each child, and the associated financial costs were calculated. Children in the late-diagnosis group presented more severe MIH, with a higher prevalence of demarcated opacities, atypical carious lesions, and atypical restorations. Although the estimated overall financial cost of treatment did not differ significantly between groups, a 2-year delay in MIH diagnosis led to more severe clinical presentations and higher expenses from the more complex interventions required. In conclusion, a 2-year delay in the diagnosis of MIH was associated with a more severe clinical presentation, necessitating more complex restorative treatments and leading to increased financial costs related to these treatments.Research Ethics Committee: CAAE 12161019.2.0000.5419, date 29.04.2019.
Indexed as
Identifiers
41087623What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.